Neurovascular Catheters Market Size to Surpass US$ 14.83 BN by 2030

The global Neurovascular Catheters market size is expected to surpass around US$ 14.83 billion by 2030 from valued at US$ 5.88 billion in 2020 and to grow at a CAGR of 10.7% from 2021 to 2030.

Growth Factors

Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.

Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38465

Report Highlights

The embolization catheters segment dominated the market with a revenue share of over 35%. The segment is expected to expand at the highest revenue-based CAGR of 10.6% during the forecast period. Based on type, the market for neurovascular catheters is segmented into microcatheters, balloon catheters, access catheters, embolization catheters, and others.

the brain aneurysm segment dominated the market with a revenue share of more than 40.0% owing to factors such as the increasing incidence of brain aneurysms, new product launches by various market players, and increasing awareness among the population about the treatment of brain aneurysm. Neurovascular catheters are used in the treatment of various diseases and conditions, such as embolic stroke, brain aneurysm, arteriovenous malformations, and other disorders.

The others segment is expected to register the highest revenue-based CAGR of 17.2% during the forecast period. The increasing number of patients suffering from atherosclerosis and intracranial artery stenosis, government initiatives, and an increase in the R&D investment are a few factors contributing to the segment growth.

The hospitals segment dominated the market in 2020 and held a revenue share of more than 60.0%. Government funding, the availability of advanced products, and the presence of skilled neurosurgeons are a few factors driving the segment. In addition, the rising number of hospitals worldwide and improving healthcare infrastructure in developing countries are driving the segment. The ambulatory surgical centers segment is expected to expand at the highest revenue-based CAGR of 10.8% during the forecast period.

North America dominated the market and accounted for a revenue share of more than 40.0% in 2020. This can be attributed to the increasing incidence of neurological diseases, supportive government policies, favorable reimbursement policies, and growing awareness.

Key Players

• Medtronic
• Stryker
• phenox GmbH
• Penumbra, Inc.
• Integer Holdings Corporation
• Terumo Corporation
• Integra LifeSciences Corporation
• Biomerics
• Acandis GmbH
• Spiegelberg GmbH & Co. KG.

Market Segmentation

• Type
  • Microcatheters
  • Balloon Catheters
  • Access Catheters
  • Embolization Catheters
  • Others
• Application
  • Embolic Stroke
  • Brain Aneurysm
  • Arteriovenous Malformations
  • Others
• End-use
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
• Regional
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38465

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333